Manufacturer record
Ossiske Life Science Pvt Ltd. F-18: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Ossiske Life Science Pvt Ltd. F-18 was declared Not of Standard Quality in July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OS-241004, Betamethasone Sodium Phosphate Tablets I.P. 0.5 mg(Medibetal) (exp Sep 2026). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conform to the IP with respect to Assay of Betamethasone sodium Phosphate eq to Betamethasone. Listed in the July 2025 alert.
Records by type
1 record linked to Ossiske Life Science Pvt Ltd. F-18 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Betamethasone Sodium Phosphate Tablets I.P. 0.5 mg(Medibetal) | Batch OS-241004Mfg Oct 2024 · Exp Sep 2026 | The sample does not conform to the IP with respect to Assay of Betamethasone sodium Phosphate eq to BetamethasoneAssay | DTL, JaipurState lab | Jul 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.